抑制凋亡信号调节激酶1减轻HIV相关肾病
该研究在HIV相关肾病(HIVAN)的Tg26小鼠模型中,于4周龄时已出现轻度肾小球硬化和蛋白尿后,给予选择性ASK1抑制剂GS-444217干预6周。结果显示GS-444217减轻了肾小球硬化、足细胞丢失、小管损伤、间质炎症和纤维化,并显著减少白蛋白尿、改善肾功能,提示抑制ASK1可能是HIVAN的潜在辅助治疗。
要点
- ASK1抑制剂GS-444217在Tg26小鼠中减轻HIVAN全部病理表现。
- 干预后白蛋白尿显著减少且肾功能改善。
- 选择性抑制ASK1可能成为HIVAN的潜在辅助治疗。
核心结论
- ASK1信号级联在Tg26小鼠HIVAN发病中起核心作用。
- 选择性抑制ASK1可能是治疗HIVAN的潜在辅助疗法。
研究设计与样本
- 在Tg26小鼠4周龄已建立轻度肾小球硬化和蛋白尿时,给予含GS-444217的鼠粮干预6周。
- 治疗后与年龄和性别匹配的对照Tg26小鼠及GS-444217治疗Tg26小鼠进行肾功能评估和组织学分析比较。
主要发现
- GS-444217减轻Tg26小鼠肾小球硬化、足细胞丢失、小管损伤、间质炎症和肾纤维化。
- 上述改善伴随白蛋白尿显著减少和肾功能改善。
临床怎么用
- 选择性ASK1抑制可能作为HIVAN的辅助治疗方向,需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease (CKD) is a common cause of morbidity and mortality in human immunodeficiency virus (HIV)-positive individuals. Among the HIV-related kidney diseases, HIV-associated nephropathy (HIVAN) is a rapidly progressive renal disease characterized by collapsing focal glomerulosclerosis (GS), microcystic tubular dilation, interstitial inflammation and fibrosis. Although the incidence of end-stage renal disease due to HIVAN has dramatically decreased with the widespread use of antiretroviral therapy, the prevalence of CKD continues to increase in HIV-positive individuals. Recent studies have highlighted the role of apoptosis signal-regulating kinase 1 (ASK1) in driving kidney disease progression through the activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase and selective ASK-1 inhibitor GS-444217 was recently shown to reduce kidney injury and disease progression in various experimental models. Therefore we examined the efficacy of ASK1 antagonism by GS-444217 in the attenuation of HIVAN in Tg26 mice. METHODS: GS-444217-supplemented rodent chow was administered in Tg26 mice at 4 weeks of age when mild GS and proteinuria were already established. After 6 weeks of treatment, the kidney function assessment and histological analyses were performed and compared between age- and gender-matched control Tg26 and GS-444217-treated Tg26 mice. RESULTS: GS-444217 attenuated the development of GS, podocyte loss, tubular injury, interstitial inflammation and renal fibrosis in Tg26 mice. These improvements were accompanied by a marked reduction in albuminuria and improved renal function. Taken together, GS-4442217 attenuated the full spectrum of HIVAN pathology in Tg26 mice. CONCLUSIONS: ASK1 signaling cascade is central to the development of HIVAN in Tg26 mice. Our results suggest that the select inhibition of ASK1 could be a potential adjunctive therapy for the treatment of HIVAN.
引用
- Chen A, Xu J, Lai H, et al. Inhibition of apoptosis signal-regulating kinase 1 mitigates the pathogenesis of human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant. 2021. PMID: 33097961. doi:10.1093/ndt/gfaa198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。